Song, P., Xu, N., & Li, Q. (2020). Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions. Cancer Manag Res.
Citação norma ChicagoSong, Peng-Fei, Ning Xu, and Qin Li. "Efficacy and Safety of Anlotinib for Elderly Patients With Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions." Cancer Manag Res 2020.
MLA引文Song, Peng-Fei, Ning Xu, and Qin Li. "Efficacy and Safety of Anlotinib for Elderly Patients With Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions." Cancer Manag Res 2020.
警告：這些引文格式不一定是100％准確.